
The U.S. Centers for Medicare & Medicaid Services has proposed a new advance care planning (ACP) quality measure, MUC202-020, that would tie reimbursement to documented end‑of‑life conversations for patients 18 and older. The measure would apply to hospitals, home health agencies, skilled nursing facilities and ambulatory surgery centers and be incorporated into the Merit‑Based Incentive Payment System. Advocates say the policy could increase hospice utilization and curb the estimated $200 billion spent on unwanted aggressive care. Stakeholders caution that the metric must avoid a simple checklist and ensure high‑quality documentation.
Vibe coding, introduced by Andrej Karpathy in early 2025, replaces traditional syntax‑heavy programming with natural‑language driven AI agents that can generate, debug, and deploy healthcare applications. The approach empowers clinicians to act as developers, dramatically lowering the cost and time...

The article outlines the legal requirement that U.S. wholesale drug distributors and third‑party logistics providers (3PLs) must hold a valid state license to handle prescription medications. It warns that unlicensed or unauthorized partners can expose patients to counterfeit, stolen, or...

The American Hospital Association (AHA) is coordinating with the FBI and other federal agencies to monitor cyber threats amid heightened geopolitical tensions, including the Iran conflict. While no specific threats to U.S. health care have been confirmed, the AHA urges...

Elation Health has introduced an AI‑driven billing engine that creates a touchless fast lane for primary‑care claims. The system pulls context from the Elation EHR—pre‑visit data, AI‑drafted notes, problem lists and medications—to suggest complete diagnosis, procedure and drug codes before...

Johnson & Johnson’s Tecvayli and Darzalex combination received FDA approval for second‑line multiple myeloma treatment, marking the third drug cleared under the Commissioner’s National Priority Voucher (CNPV) program. The decision was rendered in just 55 days after J&J’s filing, thanks...
Meritus Health launched the Go for Bold campaign in 2020, aiming to shed 1 million lb across Washington County, Maryland by 2030. By December 2024 the initiative recorded more than 160,000 lb lost among 7,700 participants, supported by 55 community partners. The program’s three‑pillared...

Mayo Clinic Platform Accelerate has announced a new 30‑week cohort of 18 digital‑health startups from across the globe. Participants will receive mentorship from Mayo clinicians and, crucially, access to millions of de‑identified longitudinal clinical records to train and validate AI models....

The FDA has issued a draft Level 1 guidance (Docket FDA‑2025‑D‑1504) titled “Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection.” The document targets both foreign and domestic manufacturers of human and animal drugs regulated by CDER,...

Emerging studies reveal that motherhood and menopause can act as neuroprotective milestones, strengthening women’s cognitive reserve and even thickening grey‑matter regions linked to memory. Researchers at Monash University found older mothers exhibit younger brain‑activity patterns, while Dr. Lisa Mosconi reports...
The March 3, 2026 AJMC/MHE webinar examined the Trump administration’s Great Healthcare Plan, focusing on most‑favored‑nation (MFN) drug pricing, the lapse of ACA marketplace subsidies, and the Inflation Reduction Act’s (IRA) impact on community oncology. Sixteen manufacturers have voluntarily adopted MFN pricing,...
Three biopharma firms—Bavarian Nordic, Sarepta Therapeutics, and Alkermes—announced the departures of long‑standing CEOs, prompting short‑term share declines. Bavarian Nordic’s Paul Chaplin steps down after a blocked $3 billion buyout, while Sarepta’s Doug Ingram leaves amid family health issues and recent product...
Immuneering Corporation announced its 2025 financial results, highlighting a 64% overall survival rate at 12 months for atebimetinib plus modified gemcitabine/nab‑paclitaxel in first‑line pancreatic cancer. The company secured FDA and EMA alignment on the design of its pivotal Phase 3 MAPKeeper 301...

Researchers have engineered a magnetic nanocarrier (IO@MBD) that combines γ‑Fe₂O₃ nanoparticles with a melamine‑based dendrimer to deliver doxorubicin. The platform achieves roughly 17 wt% drug loading, remains dispersible in water, and releases the drug preferentially under acidic conditions typical of tumor...
Researchers from Tezpur University and the University of Illinois Urbana‑Champaign identified blood‑based metabolic signatures that distinguish gallbladder cancer patients—both with and without gallstones—from individuals with gallstones alone. Using untargeted metabolomics, they detected 180 to 225 altered metabolites, many linked to...

Johnson & Johnson announced FDA approval of the Tecvayli (teclistamab) and Darzalex Faspro (subcutaneous daratumumab with hyaluronidase) combination for adults with relapsed/refractory multiple myeloma who have received at least one prior line of therapy. The approval is grounded in the Phase III...
Seqster has introduced 1‑Click DataLake, a real‑world data platform that aggregates anonymized electronic health‑record information from over 150 million patients and 200,000 clinicians across the United States. The solution delivers real‑time, longitudinal patient journeys to speed trial design, feasibility assessments, and...
Liberate Bio announced it has secured both exclusive and non‑exclusive licenses for patents covering chimeric antigen receptor (CAR) designs specifically engineered for myeloid cells such as monocytes and macrophages. The patents, obtained from Carisma Therapeutics and the University of Pennsylvania,...

Rethink Behavioral Health unveiled Session Note AI, an artificial‑intelligence driven documentation tool for applied behavior analysis (ABA) clinicians. The solution creates structured session summaries directly from real‑time session data, cutting manual entry and ensuring compliance with payer standards. It promises...

The pharmaceutical industry has finally delivered an oral GLP‑1 weight‑loss pill, with Novo Nordisk launching an oral version of Wegovy earlier this year. Eli Lilly’s oral GLP‑1 candidate, orforglipron, is expected to receive approval imminently. Oral formulations overcome the injection barrier that...
Digital Health and Care Wales (DHCW) has launched a £4.9 million procurement for a National Intelligent Integrated Audit Solution to monitor user access across the NHS Wales single patient record, clinical applications and data repositories. The cloud‑based platform must ingest audit...

Kainova Therapeutics, formerly Domain Therapeutics, announced a Series B funding round to advance its next‑generation GPCR‑modulating platform aimed at reversing tumor immunosuppression. The rebrand signals a strategic shift toward a broader oncology focus, leveraging GPCR pathways that control immune cell trafficking....

LexisNexis Risk Solutions is expanding its identity‑verification suite within Epic’s Connection Hub, enabling U.S. hospitals to embed advanced security tools directly into MyChart. The integration adds AI‑driven behavioral analytics, OTP authenticators, and other modular components to protect patient health data...

Harrison.ai has received U.S. FDA 510(k) clearance for its Acute Infarct Triage software, which analyzes non‑contrast CT brain scans to identify acute ischemic strokes. In validation studies the algorithm achieved roughly 89% sensitivity on thin‑slice CT and 86% on thicker...
Medical imaging systems such as MRI and CT are hitting a thermal latency gap where millisecond‑scale heat spikes outpace conventional liquid cooling loops. SkySpigot proposes a passive vacuum‑sorption architecture that captures these spikes using a rapid flash‑absorption phase change and...
Polymer welds are integral to medical devices, yet their fatigue resistance often goes untested. EWI’s recent study showed that under‑welded joints, which lack intermolecular diffusion, appear flawless but fail quickly under cyclic loading. Using Heated After Cross‑Section (HACS) analysis, the...
The European Commission unveiled a Health Package that revises the MDR/IVDR, removes the five‑year certificate cap and introduces risk‑based surveillance, while hard‑wiring cybersecurity reporting and aligning high‑risk AI obligations with the AI Act. The package also launches the first phase...

Roche and Zealand Pharma disclosed Phase‑II (ZUPREME‑1) results for petrelintide, an amylin‑analog injected weekly, in 493 overweight or obese adults (mean BMI 37 kg/m²) with weight‑related comorbidities. The trial evaluated five dose levels against placebo over 42 weeks and met its primary endpoint,...
:max_bytes(150000):strip_icc():format(jpeg)/letrozole-femara-for-fertility-success-rates-safety-1960195-9dcd7e59b80546adb1c468ba927c6711.jpg)
Letrozole (Femara) is increasingly prescribed to induce ovulation in patients with polycystic ovary syndrome and unexplained infertility, often replacing clomiphene (Clomid) as the preferred first‑line therapy. Clinical studies show letrozole delivers higher ovulation and live‑birth rates while reducing the incidence...
:max_bytes(150000):strip_icc():format(jpeg)/botox-injection-530449582-577168d85f9b585875ba2720.jpg)
Botox injections are generally deemed safe for nursing parents, though scientific data are scarce. Experts advise breastfeeding before the procedure and waiting several hours afterward to further limit any potential toxin transfer. The treatment’s minimal systemic absorption means the risk...
NHS England launched a “Tap the NHS App” campaign urging patients to enable push notifications for appointment reminders. A Censuswide survey found 12% of respondents forgot appointments and 11% arrived late, amounting to an estimated 16 million missed GP visits in...
Pregnant women face heightened risks when consuming raw or undercooked sushi due to potential Listeria infection, mercury exposure, and parasites. Maternal‑fetal specialist Dr. Cara Dolin advises eliminating raw fish, sashimi, nigiri, and high‑mercury species such as shark and swordfish. Safe...
Hypertrophic cardiomyopathy (HCM) is divided into obstructive and nonobstructive forms, each defined by how thickened heart muscle affects blood flow. Both share genetic origins and similar symptoms such as shortness of breath and palpitations, but obstructive HCM creates a dynamic...

Thyme Care has launched an Integrated Social Support (ISS) model that places licensed master‑level social workers as the first point of contact for cancer patients. The model proactively screens 100% of members at enrollment, uncovering that 53% face financial toxicity,...
Researchers at POSTECH and Ewha Womans University have created “Immune‑Shield,” a sprayable adhesive microgel that locally delivers immunosuppressive drugs onto transplanted organ surfaces. The mussel‑inspired coating adheres robustly in wet environments, providing sustained release and dramatically increasing graft survival in...

Nigerian‑born entrepreneur Tolu Fagbola, together with his US‑based brother, launched Vimedra to apply voice‑AI and predictive analytics to US healthcare. Their patent‑pending algorithm fuses social determinants with clinical data, creating risk profiles that flag patients likely to generate costly emergency...

A recent double‑blind trial found that a combination of two GLP‑1 receptor agonists cut fat mass significantly while sparing lean muscle in adults with obesity. Over 24 weeks, participants lost an average of 5 % body fat, with lean mass decline...
Helus Pharma reported Phase II data for its psychedelic candidate HLP004, indicating symptom improvement in generalized anxiety disorder patients for up to six months. However, the trial’s low‑dose active control arm showed similar efficacy, making it difficult to isolate the...
Helus Pharma reported Phase II data for its psychedelic candidate HLP004 in generalized anxiety disorder, showing symptom improvement lasting six months. However, the trial’s active low‑dose control produced outcomes similar to the therapeutic dose, making it difficult to isolate the drug’s...

Australian biotech firm CSL Seqirus has secured a contract with Canada’s Public Health Agency to deliver up to 15 million doses of a cell‑based, adjuvanted pandemic influenza vaccine if the WHO declares a pandemic. The doses will be manufactured at CSL...

India’s leading pregnancy detection brand PregaNews has launched a digital film ahead of International Women’s Day to spark open conversations about postpartum depression. The short film highlights how many new mothers silently endure emotional and physical strain, normalising these challenges...

A 56‑year‑old Chinese patient became the first living person to be connected to a genetically modified pig liver via extracorporeal perfusion, keeping him alive until a human liver transplant could be performed. The operation, carried out at Xijing Hospital, used...

Researchers are exposing a century‑long blind spot in biomedical science: the systematic exclusion of women’s bodies from data. Since the NIH’s 2016 mandate to treat sex as a biological variable, large‑scale disaggregation of health datasets has revealed that women live...
A Lancet analysis shows that after President Trump falsely linked acetaminophen to autism, emergency‑room orders for Tylenol among pregnant patients fell up to 20%, while prescriptions for the unproven autism treatment leucovorin in children rose 71%. The study examined 88,857...

HL7 announced the Caliper FHIR Accelerator, a new implementation community focused on standardizing medical device data exchange. The initiative builds on HL7’s 2025 effort and joins existing FHIR accelerators such as Argonaut and CARIN. Founding members Dexcom and GE HealthCare...

Angelalign Technology has launched a recycling program for used clear aligners in partnership with TerraCycle, covering dental and orthodontic practices across Australia and New Zealand. The initiative uses TerraCycle’s Zero Waste Box system to collect multi‑layered plastic aligners, which are...
The U.S. Department of Health and Human Services announced that about 50 medical schools across 31 states will add at least 40 hours of nutrition training to their four‑year undergraduate curricula starting this fall. The initiative, driven by HHS Secretary...
Tenosynovial giant cell tumour (TGCT) is a rare, locally aggressive neoplasm driven by CSF‑1 over‑expression. The phase 3 MANEUVER trial evaluated pimicotinib, a selective CSF1R kinase inhibitor, against placebo in patients with inoperable or relapsed diffuse‑type TGCT. Results demonstrated statistically significant...
The White House briefing on Sept 22 2025 linking prenatal acetaminophen to autism and promoting leucovorin was followed by an interrupted‑time‑series analysis of the Epic Cosmos database. Emergency‑department orders for paracetamol among pregnant women fell 10% (OER 0.90) while use among non‑pregnant women showed...

The Consolidated Appropriations Act of 2026 (CAA 2026) introduces sweeping federal regulation of pharmacy benefit managers (PBMs) for employer‑sponsored group health plans. It mandates full 100 percent rebate pass‑through and detailed compensation disclosure, with semi‑annual reporting requirements taking effect for calendar‑year plans...